A clinical trial to study the effectiveness of 50 millesimal potenty in homoeopathic management of migraine in adult age group.

Effectiveness of 50 millesimal potency in the homoeopathic management of migraine in adult age group a non controlled experimental study. - Nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/07/090383

Enrollment

315

Registered

2025-07-07

Start date

Unknown

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G431- Migraine with aura Health Condition 2: G430- Migraine without aura

Interventions

Intervention1: individualised homoeopathic remedy i 50 millesimal potency: homoeopathic medicine will be prescribed in 50 millesimal poteny based on principals of homoeopathic posology at regular fo

Eligibility

Inclusion criteria

Inclusion criteria: Cases of Migraine with and without aura. Cases of Migraine of adult age group Cases of Migraine of all gender. Cases of Migraine of all socio-economic status.

Exclusion criteria

Exclusion criteria: Cases of Chronic Migraine. Cases of Migraine on other medication 3 months before the commencement of study. Cases of Migraine with other systemic co-morbidities. Pregnant women and lactating women. Immuno-compromised patients.

Design outcomes

Primary

Measure	Time frame
improvement in VAS and MIDAS score.Timepoint: improvement in VAS score every month and MIDAS score every 3 months.	—

Secondary

Measure	Time frame
nillTimepoint: nill	—

Countries

India

Contacts

Public ContactDr Sapna Yadav

YMT Homoeopathic medical College,Organon of mediicine Department

sneha5@gmail.com9322506976

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026